Navigation Links
Olympus Biotech Names Oliver Burckhardt to President North America
Date:5/23/2011

HOPKINTON, Mass., May 23, 2011 /PRNewswire/ -- Olympus Biotech, an Olympus Corporation company, today announced the appointment of Oliver Burckhardt to the position of president of Olympus Biotech Corporation. In his new role, Mr. Burckhardt will lead the company's North American business and focus on expanding opportunities for the emerging regenerative medicine market. Mr. Burckhardt will also become a member of the Olympus Biotech Board of Directors.

"With nearly 20 years in the medical device industry, Oliver's extensive knowledge of the industry and global leadership experience will prove invaluable as we continue to grow Olympus Biotech," said Hitoshi Mizuno, CEO Olympus Biotech Corporation. "We look forward to benefiting from his immense expertise as we continue to lead the creation of this dynamic new field of medicine."

Before joining Olympus Biotech, Mr. Burckhardt most recently served as the international president and CEO of Scient'x Corp in Paris, France, where his strategic vision redefined the company's direction and resulted in double-digit growth. Mr. Burckhardt also served as president of Orthofix, Inc., where he was responsible for the global spine business unit. Prior to that, Mr. Burckhardt spent nine years with Aesculap, Inc. in various sales and marketing positions, including vice president of sales and marketing for the Aesculap Spine division in the United States.

"The Vision of Olympus Biotech to advance into regenerative medicine is the next logical step in the treatment of many medical pathologies and conditions. I am excited about the overall strategic thinking and the assets that are already in place, within Olympus, which represent a perfect starting point for this future oriented strategy," said Mr. Burckhardt. He added, "I look forward to joining the talented team at Olympus Biotech and leveraging my experience in the industry to generate further growth and success."

About Olympus Biotech Corporation

Olympus Biotech was established in December, 2010 as a wholly owned company of Olympus Corporation. The vision of Olympus Biotech is to improve the patient Quality of Life by developing and distributing Regenerative Medicine that stimulate the intrinsic healing capacity in the living body by the technological development of growth factors and biomaterials.

Media Contact:
Jessica Nelson
Kwittken & Company
(646) 747-7141
jnelson@kwitco.com


'/>"/>
SOURCE Olympus Biotech Corporation
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Gumz to Retire as President and CEO of Olympus Corporation of the Americas
2. Stryker Completes Sale of OP-1 for use in Orthopaedic Bone Applications to Olympus
3. Stryker Announces Definitive Agreement to Sell OP-1 for Use in Orthopaedic Bone Applications to Olympus
4. Olympus Launches 2011 National Innovation Awards Program
5. Olympus America Licenses Digital Pathology Patents to BioImagene, Inc.
6. Omnyx Licenses Olympus Digital Pathology Patents
7. Venture-Backed Biotech Generates Quicker Exits but Lower Multiples than Medical Device
8. Generex Biotechnology Corporation CEO Presentation Now Available for On-Demand Viewing at RetailInvestorConferences.com
9. Generex Biotechnology Corporation CEO to Present Live, Online at RetailInvestorConferences.com on May 5th
10. Centocor Ortho Biotech Products, L.P. Voluntarily Withdraws NDA for Trabectedin
11. Immune Design Corp. Appoints Pharma and Biotech Executive Carlos V. Paya, MD, PhD as Chief Executive Officer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/22/2017)... , Feb. 22, 2017  Corin Group announced today ... device used to treat patients with both a massive ... arthritis. The condition, known as cuff tear arthropathy, causes ... The Humelock Reversed Shoulder System, which ... technology company based near Lyon, France ...
(Date:2/22/2017)... , Feb. 22, 2017  Known for selling ... cabinets, the widow of prominent California ... should know something else about the British conglomerate that ... immorally by attempting to steal her late husband,s invention, ... and operated by Dr. Gilbert until his violent death ...
(Date:2/22/2017)... PUNE, India , February 22, 2017 /PRNewswire/ ... Allied Market Research, titled, "Radiology Information System Market by Type, ... Industry Forecast, 2014-2022," the radiology information system market was valued ... $941 million by 2022, growing at a CAGR of 5.9% ... held over three-fifths share of the total market in 2015. ...
Breaking Medicine Technology:
(Date:2/22/2017)... ... 2017 , ... Secure Exchange Solutions, the leading provider of ... health information exchanges, physicians and patients, announced today that SES Direct earned the ... IT Module Certification via Drummond Group LLC, an Authorized Certification Body (ACB). This ...
(Date:2/22/2017)... ... February 22, 2017 , ... In a 2012 survey, over ... not filling a prescription because they could not afford to pay for it. ... were 30-60%*. At the same time, hospitals, pharmacies, manufacturers and nursing ...
(Date:2/22/2017)... ... February 22, 2017 , ... Using the power of the ... simple online checklist. Over a period of just 24 months, thousands of individuals interested ... online checklist called T.A.D. , “The internet is not getting quieter. In fact it’s ...
(Date:2/22/2017)... ... 2017 , ... Bellus Medical, a leader in medical aesthetics, ... of Platelet Rich Plasma (PRP). PRP systems are used by physicians in areas ... and provide a faster and more efficient healing process. There are many systems ...
(Date:2/22/2017)... ... , ... Super-Sod will attend the Athens Home Show with a brand new ... from Super-Sod’s simple Athens Home Show booth of 2016, this year’s exhibit space includes ... Chris Roquemore constructed furniture from recycled pallet wood at the Super-Sod farm in Fort ...
Breaking Medicine News(10 mins):